Zhilong Ma

1.2k total citations
34 papers, 476 citations indexed

About

Zhilong Ma is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhilong Ma has authored 34 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 13 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhilong Ma's work include Pancreatitis Pathology and Treatment (14 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Pediatric Hepatobiliary Diseases and Treatments (5 papers). Zhilong Ma is often cited by papers focused on Pancreatitis Pathology and Treatment (14 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Pediatric Hepatobiliary Diseases and Treatments (5 papers). Zhilong Ma collaborates with scholars based in China, Belgium and Singapore. Zhilong Ma's co-authors include Zhenshun Song, Tingsong Yang, Guodong Song, Hongbo Meng, Bo Zhou, Zhengyu Hu, Daohai Qian, Jian Gong, Weidi Yu and Jia Zhou and has published in prestigious journals such as Chemical Communications, Gut and International Journal of Molecular Sciences.

In The Last Decade

Zhilong Ma

32 papers receiving 470 citations

Peers

Zhilong Ma
Dawei Li China
Zhilong Ma
Citations per year, relative to Zhilong Ma Zhilong Ma (= 1×) peers Dawei Li

Countries citing papers authored by Zhilong Ma

Since Specialization
Citations

This map shows the geographic impact of Zhilong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhilong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhilong Ma more than expected).

Fields of papers citing papers by Zhilong Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhilong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhilong Ma. The network helps show where Zhilong Ma may publish in the future.

Co-authorship network of co-authors of Zhilong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Zhilong Ma. A scholar is included among the top collaborators of Zhilong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhilong Ma. Zhilong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ma, Zhilong, Jie Hua, Miaoyan Wei, et al.. (2025). The pancreatitis-cancer transformation-related factor, human rhomboid family-1, promotes pancreatic cancer progression through the SRC/YAP signaling pathway. Translational Oncology. 54. 102346–102346. 1 indexed citations
4.
Xiao, Mingming, Rong Tang, Haoqi Pan, et al.. (2024). TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality. Gut. 74(3). 410–423. 3 indexed citations
6.
Ma, Zhilong, Zhengyu Hu, Jie Hua, et al.. (2023). Exosomes from TNF-α preconditioned human umbilical cord mesenchymal stromal cells inhibit the autophagy of acinar cells of severe acute pancreatitis via shuttling bioactive metabolites. Cellular and Molecular Life Sciences. 80(9). 257–257. 9 indexed citations
7.
Ma, Zhilong, Jie Hua, Jiang Liu, et al.. (2023). Mesenchymal Stromal Cell-Based Targeted Therapy Pancreatic Cancer: Progress and Challenges. International Journal of Molecular Sciences. 24(4). 3559–3559. 9 indexed citations
9.
Zuo, Junqing, Zhilong Ma, Wennian Yu, et al.. (2022). The Burden of Colorectal Cancer Attributable to Diet Low in Fiber from 1990 to 2019: A Global, Regional and National Analysis. The journal of nutrition health & aging. 26(12). 1061–1069. 6 indexed citations
10.
Yang, Tingsong, et al.. (2022). Chinese and Global Burdens of Gastrointestinal Cancers From 1990 to 2019. Frontiers in Public Health. 10. 941284–941284. 29 indexed citations
11.
Zhao, Dongbo, et al.. (2022). Bone marrow-derived mesenchymal stem cells ameliorate severe acute pancreatitis by inhibiting oxidative stress in rats. Molecular and Cellular Biochemistry. 477(12). 2761–2771. 8 indexed citations
12.
Ma, Zhilong, Weiwei Liu, Jia Zhou, et al.. (2022). Management and long-term outcomes of acute right colonic diverticulitis and risk factors of recurrence. BMC Surgery. 22(1). 132–132.
13.
Yang, Tingsong, Xue Zhou, Zhilong Ma, et al.. (2022). A nomogram for predicting stones recurrence in patients with bile duct stones undergoing laparoscopic common bile duct exploration. Annals of Gastroenterological Surgery. 6(4). 543–554. 3 indexed citations
14.
16.
Song, Guodong, Jia Zhou, Weidi Yu, et al.. (2020). Long noncoding RNA H19 regulates the therapeutic efficacy of mesenchymal stem cells in rats with severe acute pancreatitis by sponging miR-138-5p and miR-141-3p. Stem Cell Research & Therapy. 11(1). 420–420. 25 indexed citations
17.
Song, Guodong, Zhilong Ma, Yuxiang Wang, et al.. (2019). Bone marrow-derived mesenchymal stem cells alleviate severe acute pancreatitis-induced multiple-organ injury in rats via suppression of autophagy. Experimental Cell Research. 385(2). 111674–111674. 16 indexed citations
18.
Song, Guodong, Zhilong Ma, Jia Zhou, et al.. (2019). Bone marrow-derived mesenchymal stem cells ameliorate severe acute pancreatitis by inhibiting necroptosis in rats. Molecular and Cellular Biochemistry. 459(1-2). 7–19. 14 indexed citations
19.
Ma, Zhilong, Bin Xu, Long Wang, et al.. (2019). Anticoagulants is a risk factor for spontaneous rupture and hemorrhage of gallbladder: a case report and literature review. BMC Surgery. 19(1). 2–2. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026